Gubra Appoints Two Co Chief Executives

Company Gubra Event Type CEO change; co-CEO appointment Modality Peptide drug discovery Asset Not applicable (governance) Target Not applicable Disease Area Obesity and metabolic disease (platform) Summary Gubra disclosed that Markus Rohrwild stepped down as CEO on November 10 and appointed CFO Kristian Borbos and…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *